首頁 > 市場調查報告書 > 製藥

藥物開發

市場調查報告書

商品編碼

1378952

藥物發現資訊學市場：2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測

Drug Discovery Informatics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日期: 2023年11月02日 | 出版商:

IMARC | 英文 145 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

概要

2022年，全球藥物發現資訊學市場規模達到30億美元。展望未來， IMARC Group預計到2028年市場規模將達到56億美元，2022-2028年複合年成長率（CAGR）為11.0%。

藥物發現資訊學是一種用於分析和解釋大量生化資料的技術解決方案。這些資料是從臨床實驗室出於研究目的進行的實驗中產生的，並用於產生有關各種藥物開發的見解。它涉及大量基於軟體和硬體的工具，用於藥物發現和開發的測序、目標資料分析、資料可視化、對接、分子建模、資料庫保護。因此，它被醫療機構、製藥和生物技術組織以及合約研究組織 (CRO) 廣泛使用。

全球醫療保健和製藥行業的顯著成長是創造積極市場前景的關鍵因素之一。此外，慢性疾病的盛行率不斷上升以及對治療罕見疾病的有效解決方案的需求不斷增加也促進了市場的成長。藥物發現資訊學被製藥組織廣泛用於分析新藥物實體和處理來自多個來源的生物資訊。此外，各種技術進步，例如創新的基於生理學的藥物動力學 (PBPK) 模擬器平台的開發，有助於透過建模和模擬預測藥物動力學結果，也是其他生長誘導因素。與此一致，政府和私人醫療機構增加投資開發孤兒藥也有助於市場成長。其他因素，包括老年人口的增加，以及生物資訊學領域廣泛的研發（R&D）活動，預計將進一步推動市場發展。

本報告回答的關鍵問題：

迄今為止，全球藥物發現資訊學市場表現如何，未來幾年將如何表現？
COVID-19 對全球藥物發現資訊學市場有何影響？
主要區域市場有哪些？
基於工作流程的市場區隔是怎樣的？
基於功能的市場區隔是什麼？
基於模式的市場區隔是什麼？
基於最終用戶的市場區隔是什麼？
產業價值鏈的各個階段是什麼？
該行業的關鍵促進因素和挑戰是什麼？
全球藥物發現資訊學市場的結構如何？誰是關鍵參與者？
產業競爭程度如何？

北美洲
- 美國
  - 市場走向
  - 市場預測
- 加拿大
  - 市場走向
  - 市場預測
亞太
- 中國
  - 市場走向
  - 市場預測
- 日本
  - 市場走向
  - 市場預測
- 印度
  - 市場走向
  - 市場預測
- 韓國
  - 市場走向
  - 市場預測
- 澳洲
  - 市場走向
  - 市場預測
- 印尼
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
歐洲
- 德國
  - 市場走向
  - 市場預測
- 法國
  - 市場走向
  - 市場預測
- 英國
  - 市場走向
  - 市場預測
- 義大利
  - 市場走向
  - 市場預測
- 西班牙
  - 市場走向
  - 市場預測
- 俄羅斯
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
拉丁美洲
- 巴西
  - 市場走向
  - 市場預測
- 墨西哥
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
中東和非洲
- 市場走向
- 按國家/地區分類的市場細分
- 市場預測

第 11 章：SWOT 分析

概述
優勢
弱點
機會
威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

概述
買家的議價能力
供應商的議價能力
競爭程度
新進入者的威脅
替代品的威脅

第 14 章：價格分析

第15章：競爭格局

市場結構
關鍵參與者
關鍵參與者簡介
- Accenture PLC
- Certara
- Charles River Laboratories Inc.
- Collaborative Drug Discovery Inc.
- Eurofins DiscoverX Products
- Infosys Ltd.
- International Business Machines Corporation
- Jubilant Biosys Limited
- Oracle Corporation
- PerkinElmer Inc.
- Selvita
- Thermo Fisher Scientific Inc.

簡介目錄圖表

Product Code: SR112023A3515

Abstract

The global drug discovery informatics market size reached US$ 3.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.6 Billion by 2028, exhibiting a growth rate (CAGR) of 11.0% during 2022-2028.

Drug discovery informatics is a technological solution used for analyzing and interpreting large volumes of biochemical data. The data is generated from the experiments conducted in clinical laboratories for research purposes and utilized for generating insights regarding the development of various drugs. It involves numerous software and hardware-based tools for sequencing, target data analysis, data visualization, docking, molecular modelling, database protection for drug discovery and development. As a result, it is widely used by healthcare institutions, pharmaceutical and biotechnology organizations and contract research organizations (CROs).

Significant growth in the healthcare and pharmaceutical industries across the globe represents one of key the factors creating a positive outlook for the market. Furthermore, the increasing prevalence of chronic medical disorders and the escalating requirement for effective solutions to treat rare diseases are also augmenting the market growth. Drug discovery informatics is widely used by pharmaceutical organizations for the analysis of new drug entities and handling of the biological information from multiple sources. Additionally, various technological advancements, such as the development of innovative Physiologically-based Pharmacokinetic (PBPK) Simulator platforms, which aid in predicting pharmacokinetic outcomes through modeling and simulation, are acting as other growth-inducing factors. In line with this, increasing investments by government and private healthcare institutions to develop orphan drugs is also contributing to the market growth. Other factors, including the rising geriatric population, along with extensive research and development (R&D) activities in the field of bioinformatics, are anticipated to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global drug discovery informatics market report, along with forecasts at the global, regional and country levels from 2023-2028. Our report has categorized the market based on workflow, function, mode and end user.

Breakup by Workflow:

Drug Discovery

Drug Development

Breakup by Function:

Sequence Analysis Platforms

Molecular Modelling

Molecular Docking

Clinical Trial Data Management

Others

Breakup by Mode:

Outsourced

In-house

Breakup by End User:

Pharmaceutical Companies

Biotechnology Companies

Contract Research Organization (CROs)

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Accenture Plc, Certara, Charles River Laboratories Inc., Collaborative Drug Discovery Inc., Eurofins DiscoverX Products, Infosys Ltd., International Business Machines Corporation, Jubilant Biosys Limited, Oracle Corporation, PerkinElmer Inc., Selvita and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

How has the global drug discovery informatics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global drug discovery informatics market?
What are the key regional markets?
What is the breakup of the market based on the workflow?
What is the breakup of the market based on the function?
What is the breakup of the market based on the mode?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global drug discovery informatics market and who are the key players?
What is the degree of competition in the industry?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Drug Discovery Informatics Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Workflow

6.1 Drug Discovery
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Drug Development
- 6.2.1 Market Trends
- 6.2.2 Market Forecast

7 Market Breakup by Function

7.1 Sequence Analysis Platforms
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Molecular Modelling
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Molecular Docking
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Clinical Trial Data Management
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 Others
- 7.5.1 Market Trends
- 7.5.2 Market Forecast

8 Market Breakup by Mode

8.1 Outsourced
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 In-house
- 8.2.1 Market Trends
- 8.2.2 Market Forecast

9 Market Breakup by End User

9.1 Pharmaceutical Companies
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Biotechnology Companies
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Contract Research Organization (CROs)
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
9.4 Others
- 9.4.1 Market Trends
- 9.4.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia-Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 Accenture PLC
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
  - 15.3.1.3 Financials
  - 15.3.1.4 SWOT Analysis
- 15.3.2 Certara
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
- 15.3.3 Charles River Laboratories Inc.
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
  - 15.3.3.3 Financials
  - 15.3.3.4 SWOT Analysis
- 15.3.4 Collaborative Drug Discovery Inc.
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
- 15.3.5 Eurofins DiscoverX Products
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
- 15.3.6 Infosys Ltd.
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
  - 15.3.6.3 Financials
  - 15.3.6.4 SWOT Analysis
- 15.3.7 International Business Machines Corporation
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
  - 15.3.7.3 Financials
  - 15.3.7.4 SWOT Analysis
- 15.3.8 Jubilant Biosys Limited
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
- 15.3.9 Oracle Corporation
  - 15.3.9.1 Company Overview
  - 15.3.9.2 Product Portfolio
  - 15.3.9.3 Financials
  - 15.3.9.4 SWOT Analysis
- 15.3.10 PerkinElmer Inc.
  - 15.3.10.1 Company Overview
  - 15.3.10.2 Product Portfolio
  - 15.3.10.3 Financials
  - 15.3.10.4 SWOT Analysis
- 15.3.11 Selvita
  - 15.3.11.1 Company Overview
  - 15.3.11.2 Product Portfolio
- 15.3.12 Thermo Fisher Scientific Inc.
  - 15.3.12.1 Company Overview
  - 15.3.12.2 Product Portfolio
  - 15.3.12.3 Financials
  - 15.3.12.4 SWOT Analysis

簡介目錄圖表

List of Figures

Figure 1: Global: Drug Discovery Informatics Market: Major Drivers and Challenges
Figure 2: Global: Drug Discovery Informatics Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Drug Discovery Informatics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Drug Discovery Informatics Market: Breakup by Workflow (in %), 2022
Figure 5: Global: Drug Discovery Informatics Market: Breakup by Function (in %), 2022
Figure 6: Global: Drug Discovery Informatics Market: Breakup by Mode (in %), 2022
Figure 7: Global: Drug Discovery Informatics Market: Breakup by End User (in %), 2022
Figure 8: Global: Drug Discovery Informatics Market: Breakup by Region (in %), 2022
Figure 9: Global: Drug Discovery Informatics (Drug Discovery) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Drug Discovery Informatics (Drug Discovery) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Drug Discovery Informatics (Drug Development) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Drug Discovery Informatics (Drug Development) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Drug Discovery Informatics (Sequence Analysis Platforms) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Drug Discovery Informatics (Sequence Analysis Platforms) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Drug Discovery Informatics (Molecular Modelling) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Drug Discovery Informatics (Molecular Modelling) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Drug Discovery Informatics (Molecular Docking) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Drug Discovery Informatics (Molecular Docking) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Drug Discovery Informatics (Clinical Trial Data Management) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Drug Discovery Informatics (Clinical Trial Data Management) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Drug Discovery Informatics (Other Functions) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Drug Discovery Informatics (Other Functions) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Drug Discovery Informatics (Outsourced) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Drug Discovery Informatics (Outsourced) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Drug Discovery Informatics (In-house) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Drug Discovery Informatics (In-house) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Drug Discovery Informatics (Pharmaceutical Companies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Drug Discovery Informatics (Pharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Drug Discovery Informatics (Biotechnology Companies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Drug Discovery Informatics (Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Drug Discovery Informatics (Contract Research Organization (CROs)) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Drug Discovery Informatics (Contract Research Organization (CROs)) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Global: Drug Discovery Informatics (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Global: Drug Discovery Informatics (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: North America: Drug Discovery Informatics Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: North America: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: United States: Drug Discovery Informatics Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: United States: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Canada: Drug Discovery Informatics Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Canada: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Asia-Pacific: Drug Discovery Informatics Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Asia-Pacific: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: China: Drug Discovery Informatics Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: China: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: Japan: Drug Discovery Informatics Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: Japan: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: India: Drug Discovery Informatics Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: India: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: South Korea: Drug Discovery Informatics Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: South Korea: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: Australia: Drug Discovery Informatics Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: Australia: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Indonesia: Drug Discovery Informatics Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Indonesia: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Others: Drug Discovery Informatics Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Others: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Europe: Drug Discovery Informatics Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Europe: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Germany: Drug Discovery Informatics Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Germany: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: France: Drug Discovery Informatics Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: France: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: United Kingdom: Drug Discovery Informatics Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: United Kingdom: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Italy: Drug Discovery Informatics Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Italy: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Spain: Drug Discovery Informatics Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Spain: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Russia: Drug Discovery Informatics Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Russia: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Others: Drug Discovery Informatics Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Others: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Latin America: Drug Discovery Informatics Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Latin America: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Brazil: Drug Discovery Informatics Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Brazil: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Mexico: Drug Discovery Informatics Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Mexico: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Others: Drug Discovery Informatics Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Others: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Middle East and Africa: Drug Discovery Informatics Market: Sales Value (in Million US$), 2017 & 2022
Figure 82: Middle East and Africa: Drug Discovery Informatics Market: Breakup by Country (in %), 2022
Figure 83: Middle East and Africa: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 84: Global: Drug Discovery Informatics Industry: SWOT Analysis
Figure 85: Global: Drug Discovery Informatics Industry: Value Chain Analysis
Figure 86: Global: Drug Discovery Informatics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Drug Discovery Informatics Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Drug Discovery Informatics Market Forecast: Breakup by Workflow (in Million US$), 2023-2028
Table 3: Global: Drug Discovery Informatics Market Forecast: Breakup by Function (in Million US$), 2023-2028
Table 4: Global: Drug Discovery Informatics Market Forecast: Breakup by Mode (in Million US$), 2023-2028
Table 5: Global: Drug Discovery Informatics Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 6: Global: Drug Discovery Informatics Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Drug Discovery Informatics Market: Competitive Structure
Table 8: Global: Drug Discovery Informatics Market: Key Players

02-2729-4219

+886-2-2729-4219